LMNX Share Price

Open 18.50 Change Price %
High 18.77 1 Day 0.03 0.16
Low 18.45 1 Week 0.45 2.47
Close 18.70 1 Month -1.43 -7.10
Volume 146301 1 Year 0.10 0.54
52 Week High 23.75
52 Week Low 17.64
LMNX Important Levels
Resistance 2 19.00
Resistance 1 18.87
Pivot 18.64
Support 1 18.53
Support 2 18.40
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Luminex Corporation (NASDAQ: LMNX)

LMNX Technical Analysis 4
As on 24th Feb 2017 LMNX Share Price closed @ 18.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 20.62 & Sell for SHORT-TERM with Stoploss of 19.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
LMNX Target for February
1st Target up-side 21.29
2nd Target up-side 22.05
3rd Target up-side 22.8
1st Target down-side 19.15
2nd Target down-side 18.39
3rd Target down-side 17.64
LMNX Other Details
Segment EQ
Market Capital 700786944.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.luminexcorp.com
LMNX Address
LMNX
12212 Technology Boulevard
Austin, TX 78727
United States
Phone: 512-219-8020
Fax: 512-219-5195
LMNX Latest News
Luminex Corporation Announces Initiation of Cash Dividend   PR Newswire (press release)   - 22nd Feb 17
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results   PR Newswire (press release)   - 07th Feb 17
Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 ...   PR Newswire (press release)   - 09th Jan 17
Luminex Corporation Receives FDA Clearance for ARIES® GBS Assay   PR Newswire (press release)   - 04th Jan 17
Luminex wins R&D 100 Award for ARIES Systems   PR Newswire (press release)   - 05th Dec 16
Luminex Corporation Reports Third Quarter 2016 Results; Raises Full Year Guidance   PR Newswire (press release)   - 01st Nov 16
Luminex Corporation Receives FDA Emergency Use Authorization for Zika Virus ...   PR Newswire (press release)   - 08th Aug 16
Luminex Corporation Receives FDA Clearance for New Molecular Test for ...   PR Newswire (press release)   - 03rd Aug 16
Luminex Corporation Completes Acquisition of Nanosphere, Inc.   PR Newswire (press release)   - 30th Jun 16
Luminex Corporation Announces Commencement of Tender Offer for All Outstanding ...   PR Newswire (press release)   - 02nd Jun 16
Interactive Technical Analysis Chart Luminex Corporation ( LMNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Luminex Corporation
LMNX Business Profile
Luminex Corporation (Luminex)develops, manufactures and sells biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The Company�s Multi-Analyte Profiling (xMAP) technology, an open architecture, multiplexing technology, allows simultaneous analysis of up to 500 bioassays from a small sample volume, a single drop of fluid, by reading biological tests on the surface of microscopic polystyrene beads called microspheres. xMAP technology combines this miniaturized liquid array bioassay capability with small lasers, digital signal processors and software. Its xMAP technology is being used within various segments of the life sciences industry, which includes the fields of drug discovery and development, and for clinical diagnostics, genetic analysis, bio-defense, food safety and biomedical research. On June 27, 2011, the Company completed its acquisition of 100% interest of EraGen Biosciences, Inc.